Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : Profit-taking puts sterling on track for worst day vs euro since February

04/06/2021 | 06:44am EDT
FILE PHOTO: Pound Sterling notes and change are seen inside a cash resgister in a coffee shop in Manchester

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh

* Graphic: Trade-weighted sterling since Brexit vote http://tmsnrt.rs/2hwV9Hv

LONDON, April 6 (Reuters) - Sterling slipped on Tuesday and was on track for its worst day against the euro in five weeks as investors took some cash off the table, while continuing to bet on a speedy re-opening of the British economy.

Expectations of a UK economic rebound, spurred by a rapid COVID-19 vaccination program, have just helped sterling to record its best quarter since 2015 versus the single currency.

But as traders returned from the long Easter weekend, the pound fell as much as 0.7% to 85.51 pence versus the euro at 1440 GMT, putting it on track for its worst session since Feb. 25.

Sterling also fell 0.5% against the dollar to $1.3844, after earlier touching $1.3919, its highest since March 19.

"It is the re-opening of London this morning that is seeing sterling under some initial pressure, as sellers have returned and taken advantage of the rally seen over the last 24 hours or so," said Stuart Cole, chief macro strategist at Equiti Capital in London.

Cole added the selling appeared to be a mixture of profit-taking and new short positions being initiated.

On Monday, the pound recorded its best day against a weakening dollar since Feb. 18, as U.S. Treasury yields held below recent highs. Low liquidity, with many parts of the world off for the Easter break, was seen exaggerating moves.

Market participants continued to expect further gains for the pound in the months ahead.

With the vaccine program rolling out rapidly across Britain and infection numbers falling, Prime Minister Boris Johnson confirmed on Monday a planned re-opening of the economy would take place next week.

Shops, gyms, hairdressers and outdoor hospitality areas in England will re-open. The government is also looking at a COVID-status certification system, or vaccine passport, to help re-open larger events.

Britain will begin the rollout of Moderna's COVID-19 vaccine in mid-April, vaccine deployment minister Nadhim Zahawi said on Tuesday, adding the inoculation program was on track to meet government targets.

Some 12 million second doses are planned to be distributed in April.

Johnson also said on Monday his government hoped non-essential international travel would resume from May 17.

(Reporting by Joice Alves; Editing by Larry King and Mark Potter)


© Reuters 2021
All news about MODERNA, INC.
05:48pMODERNA  : Manitoba eyes shift to larger centres for temporary COVID-19 vaccine ..
AQ
05:04pU.S. Vaccine Panel Delays Vote on J&J Covid-19 Shot's Clot Risk -- 2nd Update
DJ
04:33pMODERNA DISCUSSES COVID-19 VACCINE M : sources
RE
04:27pMODERNA  : Clinics in Toronto hot spots run out of vaccines as cases continue to..
AQ
04:27pU.S. Vaccine Panel Opts Not to Vote on J&J Covid-19 Shot's Clot Risk -- Updat..
DJ
04:17pModerna, Valero rise; Stitch Fix, Discovery fall
AQ
02:31pMODERNA  : COVID-19 shot production unlikely to rise significantly in next few m..
RE
02:24pMODERNA  : Ontario sees vaccine supply issues, Ottawa keeps AstraZeneca on the m..
AQ
02:15pMODERNA  : U.S. administers 194.8 mln doses of COVID-19 vaccines - CDC
RE
02:12pMODERNA  : COVID SCIENCE-Moderna vaccines promising vs variants in mouse study; ..
RE
More news
Financials (USD)
Sales 2021 17 066 M - -
Net income 2021 9 101 M - -
Net cash 2021 11 099 M - -
P/E ratio 2021 7,23x
Yield 2021 -
Capitalization 64 096 M 64 096 M -
EV / Sales 2021 3,11x
EV / Sales 2022 3,31x
Nbr of Employees 1 300
Free-Float 89,0%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 165,50 $
Last Close Price 160,03 $
Spread / Highest target 30,0%
Spread / Average Target 3,42%
Spread / Lowest Target -50,0%
EPS Revisions
Managers and Directors
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.43.30%59 963
LONZA GROUP AG-3.59%44 152
IQVIA HOLDINGS INC.15.81%39 790
CELLTRION, INC.-12.26%38 402
SEAGEN INC.-19.56%25 544
HANGZHOU TIGERMED CONSULTING CO.,LTD-14.68%17 801